Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

Periods Can Take Years to Return After Long-Term Birth Control
SocialMar 14, 2026

Periods Can Take Years to Return After Long-Term Birth Control

When I came off birth control after 13 years, I expected my period to come back within a month or two. It took 3.5 years. Most doctors will tell you your cycle should return within 3 months. For some women...

By Preethi Kasireddy
Chris Bradley: Better Science for Longevity
PodcastMar 14, 20260 min

Chris Bradley: Better Science for Longevity

In this episode, host Rizim Tom chats with Chris Bradley of MatterBio about the science of longevity, focusing on how genomic damage drives the hallmarks of aging. Bradley explains that while cells constantly renew, DNA damage from internal sources like...

By Razib Khan: Unsupervised Learning
Micro-Cages Enable Precise Manipulation of Cell Clusters
SocialMar 14, 2026

Micro-Cages Enable Precise Manipulation of Cell Clusters

These micro-cages are designed to hold and manipulate tiny cell clusters in miniaturized lab-on-a-chip devices. https://spectrum.ieee.org/lab-on-a-chip-grippers?share_id=9241061

By IEEE Spectrum Threads
EGFR Vs. ALK: How Molecular Profiling Defines Lung Cancer Treatment
BlogMar 14, 2026

EGFR Vs. ALK: How Molecular Profiling Defines Lung Cancer Treatment

Comprehensive molecular profiling of two stage IV NSCLC patients revealed distinct driver alterations—an EGFR exon 19 deletion in one and an EML4‑ALK fusion in the other—prompting personalized first‑line therapy with osimertinib and alectinib respectively. Both patients experienced rapid symptomatic improvement and enhanced...

By KevinMD
If You Want Doctors to Listen, Stop Talking Like This
BlogMar 14, 2026

If You Want Doctors to Listen, Stop Talking Like This

The author attended a Vaccine Policy Day event in Washington, D.C., and observed that extreme language—such as the “Massive Epidemic of Vaccine Injury” title—deters mainstream physicians from engaging. While legitimate safety concerns exist, alarmist rhetoric causes doctors to dismiss the...

By Dr. Gator - Between a Shot and Hard Place
Re: Standard Chemoradiotherapy with Concurrent and Adjuvant Camrelizumab in Patients with High Risk Nasopharyngeal Carcinoma: Multicentre, Randomised, Open Label, Phase...
NewsMar 14, 2026

Re: Standard Chemoradiotherapy with Concurrent and Adjuvant Camrelizumab in Patients with High Risk Nasopharyngeal Carcinoma: Multicentre, Randomised, Open Label, Phase...

A phase‑3 BMJ trial reported that adding camrelizumab to standard chemoradiotherapy improved 36‑month progression‑free, distant‑metastasis‑free and locoregional‑recurrence‑free survival in high‑risk nasopharyngeal carcinoma. The protocol combined two concurrent cycles with 17 adjuvant cycles, yet only 61.9% of patients completed the full...

By BMJ (Latest)
NeuroCognitive Architectures in Healthcare Technology: Analysis of Behavioural Economics and NeuroMarketing Strategies
NewsMar 14, 2026

NeuroCognitive Architectures in Healthcare Technology: Analysis of Behavioural Economics and NeuroMarketing Strategies

The healthcare technology sector, now worth roughly $584 billion, is being reshaped by the fusion of neuroscience, artificial intelligence, and behavioural economics. MedTech firms are adopting neuromarketing tactics—such as framing, affordability illusion, and the rule of three—to influence patient and clinician...

By healthcare.digital
In South Carolina, Measles Shows How Far Apart Neighbors Can Be on Vaccines
NewsMar 14, 2026

In South Carolina, Measles Shows How Far Apart Neighbors Can Be on Vaccines

Spartanburg County, South Carolina, has become the epicenter of the largest U.S. measles outbreak in decades, with nearly 1,000 confirmed cases. School vaccination rates have slipped to just under 89%, well below the 95% herd‑immunity threshold needed to block transmission....

By NPR (Health)
Zydus Lifesciences’ Anaemia Drug Desidustat Gets China Approval
NewsMar 14, 2026

Zydus Lifesciences’ Anaemia Drug Desidustat Gets China Approval

Zydus Lifesciences has received NMPA approval for its oral anaemia drug Desidustat, targeting renal anaemia in adult chronic kidney disease patients who are not on dialysis. The therapy, a hypoxia‑inducible factor‑prolyl hydroxylase inhibitor, demonstrated efficacy and safety in Chinese Phase III...

By The Hindu BusinessLine – Companies
The Lost Art of Connection: Why Medicine Needs to Slow Down
BlogMar 14, 2026

The Lost Art of Connection: Why Medicine Needs to Slow Down

Dean Robosa, MD reflects on how modern medicine has become a rushed, transactional business, leaving little time for deep doctor‑patient conversations. He notes that essential assessments like the Geriatric Depression Scale are rarely performed because clinicians are pressured to prioritize...

By KevinMD
First Human Age‑Reversal Trial Targets Whole‑Body Reset
SocialMar 14, 2026

First Human Age‑Reversal Trial Targets Whole‑Body Reset

The first human age-reversal trial is officially happening. But before the FDA cleared it, Harvard professor David Sinclair had to pull off a mice experiment most scientists thought was impossible: "These mice had their optic nerve regenerated. We were able to...

By John Cumbers
5 Best Laboratory Information Systems for Pathology Workflows
NewsMar 14, 2026

5 Best Laboratory Information Systems for Pathology Workflows

Pathology laboratories are adopting specialized Laboratory Information Systems (LIS) to streamline specimen accessioning, case management, and report generation. Core features such as barcode‑based tracking, automated workflow routing, and customizable reporting improve accuracy and reduce turnaround times. Enterprise solutions add multi‑site...

By Healthcare Guys
7 Signs Your Child Might Benefit From Early Orthodontic Intervention
NewsMar 14, 2026

7 Signs Your Child Might Benefit From Early Orthodontic Intervention

Early orthodontic, or interceptive, treatment targets children aged 6‑10 to guide jaw growth and prevent complex problems later. By age seven enough permanent teeth have erupted for orthodontists to assess bite relationships, space availability, and airway issues. The article outlines...

By Healthcare Guys
‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
NewsMar 14, 2026

‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control

The American Heart Association and American College of Cardiology have lowered the systolic blood‑pressure target for older adults, now urging clinicians to aim for readings below 130 mmHg. Emerging data linking hypertension to cognitive decline have accelerated this shift, prompting more...

By New York Times – Health
Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado
NewsMar 14, 2026

Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado

KFF Health News correspondents highlighted two state‑level policy debates: Georgia's proposed Medicaid work mandate targeting adults 50‑64, and Colorado's bill to limit wage garnishment for medical debt. In Georgia, the rule would require 20 hours of work or community service...

By KFF Health News
Beyond Language and Geography: Recognising Study Significance (Re: Language and Geographical Bias Limits Global Health Research)
NewsMar 14, 2026

Beyond Language and Geography: Recognising Study Significance (Re: Language and Geographical Bias Limits Global Health Research)

In a rapid response to Ndong’s BMJ commentary, Professor Shigeki Matsubara acknowledges that non‑English and regionally focused papers often receive less global attention, potentially narrowing the evidence base for evidence‑based medicine. He argues that the core issue is not language...

By BMJ (Latest)
YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency...
BlogMar 14, 2026

YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency...

YolTech Therapeutics announced FDA approval of its IND for YOLT-202, an in vivo adenine base‑editing therapy targeting Alpha‑1 Antitrypsin Deficiency. The clearance permits an open‑label, single‑dose Phase 2/3 expansion study across the U.S. and other regions. In the ongoing first‑in‑human trial,...

By HealthTech HotSpot
Reablement Insights From Community Nursing Assistants Interviews
NewsMar 14, 2026

Reablement Insights From Community Nursing Assistants Interviews

A new BMC Geriatrics interview study examined community‑based nursing assistants delivering reablement to home‑dwelling seniors. Assistants reported strong purpose in fostering independence but faced time pressures, training gaps, and limited resources. The research highlighted the emerging role of assistive technologies...

By Bioengineer.org
Confidential Health Records From UK BioBank Project Exposed Online
NewsMar 14, 2026

Confidential Health Records From UK BioBank Project Exposed Online

The Guardian uncovered that UK Biobank’s confidential health records have been posted online dozens of times, often through researchers accidentally uploading datasets to GitHub. The leaked files, while lacking names and addresses, contain diagnoses, dates, sex and birth month/year for...

By The Guardian – Science
African Countries Consider ‘Vice Taxes’ to Help Fill USAID Cuts
NewsMar 14, 2026

African Countries Consider ‘Vice Taxes’ to Help Fill USAID Cuts

African NGOs are grappling with a sudden 30% budget loss after the U.S. shut down USAID, while European and private philanthropy contributions have also slipped, leaving services for women, children, and HIV patients underfunded. In response, several African governments are...

By The Japan Times – Books
For Kidney Failure Patients, Hope Springs Local in Batangas
NewsMar 14, 2026

For Kidney Failure Patients, Hope Springs Local in Batangas

On World Kidney Day, the Renal and Transplant Institute (RTI) in Batangas highlighted kidney transplantation as a viable alternative to dialysis for stage‑5 chronic kidney disease patients. The Philippine Society of Nephrology reports that one Filipino develops chronic renal failure...

By Philippine Daily Inquirer – Business
Immune Checkpoint Dysregulation Drives Pediatric Bronchiolitis Severity
NewsMar 14, 2026

Immune Checkpoint Dysregulation Drives Pediatric Bronchiolitis Severity

A new multicenter study links dysregulated immune checkpoint pathways, especially PD‑1/PD‑L1 and CTLA‑4, to heightened severity in pediatric bronchiolitis. Researchers measured checkpoint molecule expression in airway samples from 312 infants and found that higher PD‑1 levels correlated with increased IL‑6,...

By Bioengineer.org
Exploring Tomorrow's Medicine with Global Leaders at ATOM
SocialMar 14, 2026

Exploring Tomorrow's Medicine with Global Leaders at ATOM

So proud to be on stage again with Serena at the ATOM event in LA talking to our dear friends Vartan Sarkissian and his father President Armen Sarkissian of Armenia 🇦🇲 about the future of medicine and healthcare 🧬 ATOM...

By David Sinclair
Google's AMIE Shows Promise, Still Needs Clinician Partner
SocialMar 14, 2026

Google's AMIE Shows Promise, Still Needs Clinician Partner

A great discussion by the brilliant @AdamRodmanMD on the new study of @Google 's AMIE (medical AI) tool, including the study's limitations. Bottom line is the tool's performance is impressive and getting better, but it's still best thought of as...

By Robert (Bob) Wachter, MD
Link Between CKM Syndrome Stage and Elderly Falls
NewsMar 14, 2026

Link Between CKM Syndrome Stage and Elderly Falls

Recent research published in the Journal of Geriatric Medicine identifies a strong correlation between the stage of CKM syndrome and the incidence of falls among older adults. The study found that individuals in advanced CKM stages experience a 30% higher...

By Bioengineer.org
Drug Patents: Near-Term Generic Threat, Mid-Term Safeguards, Tirzepat
SocialMar 14, 2026

Drug Patents: Near-Term Generic Threat, Mid-Term Safeguards, Tirzepat

AI: Short-Term Cliffs (0-3 years remaining): Drugs like sacubitril/valsartan, dapagliflozin, pembrolizumab, ocrelizumab, daratumumab, and apixaban face imminent generic/biosimilar pressure Mid-Term Protection (4-7 years): Risankizumab and dupilumab have solid runway, supported by ongoing label expansions. Long-Term (8+ years): Tirzepatide's robust patents position it...

By Peter Suzman
Judge Denies Epic's Dismissal Motion, Loss Expected
SocialMar 14, 2026

Judge Denies Epic's Dismissal Motion, Loss Expected

Another big Epic litigation update, as Judge Fillmore denied Epic's Motion to Dismiss in full in Texas v. Epic. It’s a loss, but somewhat of an expected one, as the state specific 91a pleading standard is a low bar. https://t.co/S9eI9qwFOV

By Brendan Keeler
Advanced eClinical Training Expands Nationwide Clinical Partner Network, Strengthening Medical Assistant Workforce Pipeline
BlogMar 14, 2026

Advanced eClinical Training Expands Nationwide Clinical Partner Network, Strengthening Medical Assistant Workforce Pipeline

Advanced eClinical Training (ACT) announced that its clinical partner network now spans more than 1,000 healthcare sites across the United States, providing externship placements for students in its medical‑assistant, phlebotomy and allied‑health programs. The company’s extern‑to‑hire model lets providers evaluate...

By HealthTech HotSpot
NY AI Ban Shields Cartel, Ignoring Uninsured Crisis
SocialMar 14, 2026

NY AI Ban Shields Cartel, Ignoring Uninsured Crisis

New York wants to ban AI that outscores doctors on medical exams. Over 900,000 New Yorkers have no insurance. 92% of low-income legal problems go unaddressed. Anti-AI NY bill S7263 isn't consumer protection. It's cartel protection. https://t.co/e9BdWuvvUB

By Garry Tan
AI Sleep Model Predicts 130+ Diseases From PSG
SocialMar 14, 2026

AI Sleep Model Predicts 130+ Diseases From PSG

SleepFM is a multimodal #AI foundation model for disease prediction. Developed by @Stanford researchers, trained on over 585K hours of polysomnography (PSG) data from 65K patients. It analyzes brain, heart, & respiratory signals to predict 130+ diseases—including dementia, cancer, and heart...

By Daniel Kraft, MD
Association Between Human Papillomavirus (HPV) Infection and Neisseria Gonorrhea Among Women Screened for HPV in A Rural Community, Southwest Nigeria:...
NewsMar 14, 2026

Association Between Human Papillomavirus (HPV) Infection and Neisseria Gonorrhea Among Women Screened for HPV in A Rural Community, Southwest Nigeria:...

A case‑control study in rural Southwest Nigeria examined co‑infection of HPV and Neisseria gonorrhoeae among 186 women. HPV‑positive participants showed a 6.45% gonorrhea prevalence versus 1.1% in HPV‑negative controls, yielding an odds ratio of 6.33 though not statistically significant (p=0.12)....

By Research Square – News/Updates
Rare Disease Spotlight: Friedreich Ataxia Moves Beyond Mitochondrial Bandages
NewsMar 14, 2026

Rare Disease Spotlight: Friedreich Ataxia Moves Beyond Mitochondrial Bandages

Friedreich ataxia (FA) received its first FDA‑approved therapy in 2023 when omaveloxolone, marketed as Skyclarys, earned accelerated approval. Biogen’s $7.3 billion acquisition of Reata Pharmaceuticals secured the drug and highlighted the market’s appetite for rare‑disease assets. Skyclarys works by activating the...

By BioCentury
Medicare Is About to Spend $100 Million on “Functional Medicine.”
BlogMar 14, 2026

Medicare Is About to Spend $100 Million on “Functional Medicine.”

The CMS Innovation Center has launched the MAHA ELEVATE pilot, earmarking $100 million to award grants to up to 30 organizations over three years beginning September 2026. The program aims to test whole‑person health approaches—including nutrition, exercise, sleep and stress management—and...

By Dr. Rubin's Substack
A Smartphone App Can Help Men Last Longer in Bed
NewsMar 14, 2026

A Smartphone App Can Help Men Last Longer in Bed

A randomized 12‑week trial evaluated Melonga, a smartphone app that teaches pelvic‑floor, mindfulness and cognitive‑behavioural techniques to men with premature ejaculation. Among the 66 participants who completed the study, average intravaginal ejaculation latency rose from 61 seconds to 125 seconds,...

By New Scientist (Health)
Kian Pee Wan May Be Harmful Due to Hidden Drug Ingredients
NewsMar 13, 2026

Kian Pee Wan May Be Harmful Due to Hidden Drug Ingredients

The FDA has issued a safety alert warning consumers not to purchase or use Kian Pee Wan, a product marketed as an appetite stimulant and weight‑gain aid. Laboratory testing revealed the supplement contains the prescription steroid dexamethasone and the antihistamine...

By FDA
Health-Related Quality of Life and Its Influence Factors in Chinese Patients with Phenylketonuria
NewsMar 13, 2026

Health-Related Quality of Life and Its Influence Factors in Chinese Patients with Phenylketonuria

A 2025 cross‑sectional survey assessed health‑related quality of life (HRQoL) in 196 Chinese phenylketonuria (PKU) patients using the EQ‑5D instrument. The cohort, average age 9.5 years, was predominantly rural (62%) with low educational attainment and modest household incomes. Mean EQ‑5D...

By Research Square – News/Updates
One in Six on Hospital Waiting List Amid Record Taxes
SocialMar 13, 2026

One in Six on Hospital Waiting List Amid Record Taxes

Wait? How is this possible. That would be 1 in 6 people are on a hospital waiting list? It's criminal how bad this countries health service is given we've had record tax income.

By Kieran Flanagan
BCBS Study: Hospital AI Billing Tools May Be Driving up Healthcare Costs by Billions
NewsMar 13, 2026

BCBS Study: Hospital AI Billing Tools May Be Driving up Healthcare Costs by Billions

Blue Cross Blue Shield’s new study links hospital AI billing tools to a sharp rise in maternity‑related costs. Analyzing tens of thousands of inpatient claims, the research found acute post‑hemorrhagic anemia diagnoses tripled at the top 10% of hospitals without...

By Becker’s Hospital Review
MA Spending 14% Higher Than FFS Medicare, Including at Nursing Homes, Driven by Coding Intensity and Enrollment Trends
NewsMar 13, 2026

MA Spending 14% Higher Than FFS Medicare, Including at Nursing Homes, Driven by Coding Intensity and Enrollment Trends

Medicare Advantage (MA) spending is projected to be 14% higher than fee‑for‑service Medicare in 2026, adding roughly $76 billion in excess costs. The gap stems from intensified diagnostic coding, a quality‑bonus program that adds $16 billion, and favorable selection that boosts payments...

By Skilled Nursing News
CMS Moves Forward with 3rd Round of Medicare Drug Negotiations
NewsMar 13, 2026

CMS Moves Forward with 3rd Round of Medicare Drug Negotiations

CMS announced that the third round of the Medicare Drug Price Negotiation Program will proceed with full manufacturer participation, covering 15 high‑cost, single‑source drugs and one drug slated for renegotiation. The agency will issue initial price offers by June 1, 2026,...

By Becker’s Hospital Review
Vaccination Boosts Survival in Multiple Myeloma Patients
SocialMar 13, 2026

Vaccination Boosts Survival in Multiple Myeloma Patients

Rates of Influenza and Pneumococcal Vaccination and Correlation with Survival in Multiple Myeloma Patients [Dec 6, 2022] @mtmdphd et al. @AjaiChari CLML https://t.co/kUQeRmdKWV #NCT02761187 #mmsm #IDonc #ClinicalTrials #caxtx https://t.co/L7r9caCcGN

By Mike Thompson, MD PhD
Tech Bills of the Week: Improved Biological Data for Research; Section 702 Reform; and More
NewsMar 13, 2026

Tech Bills of the Week: Improved Biological Data for Research; Section 702 Reform; and More

Congress introduced a suite of bipartisan bills aimed at shaping America’s AI future. The AI‑Ready Bio‑Data Standards Act directs NIST to create standards for biological datasets used in machine‑learning research, while the Government Surveillance Reform Act tightens warrant requirements for...

By FCW (GovExec Technology)
Navigating Myeloma MRD: Risks, Benefits, and Treatment Decisions
SocialMar 13, 2026

Navigating Myeloma MRD: Risks, Benefits, and Treatment Decisions

MT @hhashmi87 #IMS25 Great Meet The Expert talk by @bdermanmd on MRD in Myeloma Risk vs benefit Who can stop treatment Active surveillance post discontinuation #mmMRD #mmsm https://t.co/YOBOPs7hQL

By Mike Thompson, MD PhD
MRD‑Negative Patients May Stop Myeloma Maintenance Therapy
SocialMar 13, 2026

MRD‑Negative Patients May Stop Myeloma Maintenance Therapy

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) - @bdermanmd et al. @ajjakubowiak #ASCO24 Abstract 106 https://t.co/FBTY7SnCxK #NCT04108624 #mmsm #mmMRD

By Mike Thompson, MD PhD
HCA’s Highest-Earning Executives in 2025
NewsMar 13, 2026

HCA’s Highest-Earning Executives in 2025

HCA Healthcare reported $6.8 billion net income on $75.6 billion revenue in 2025, driving a $0.7 billion rise in total executive compensation to $32.9 billion. CEO Sam Hazen’s pay jumped $2.7 million, reaching $26.46 million, while the five highest‑earning officers collectively earned over $53 million. The company...

By Becker’s Hospital Review
Clinicians Show Mixed Adoption of MRD in Myeloma
SocialMar 13, 2026

Clinicians Show Mixed Adoption of MRD in Myeloma

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol https://t.co/8zhxYfYwZQ #mmsm #mmMRD https://t.co/QTlR2gv5Q0

By Mike Thompson, MD PhD
Understanding MRD's Role in Multiple Myeloma Management
SocialMar 13, 2026

Understanding MRD's Role in Multiple Myeloma Management

#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by @bdermanmd to @symplur @healthhashtags https://t.co/grkkiox2yh #mmsm No longer available at Symplur https://t.co/IGDrNALHBP

By Mike Thompson, MD PhD
A New Lifeline Helps Inmates Transition to Life Outside the Bars
NewsMar 13, 2026

A New Lifeline Helps Inmates Transition to Life Outside the Bars

California’s Medicaid program now reimburses health care services provided inside jails and prisons, giving inmates access to prescription medication, mental‑health treatment, and case‑management before release. The policy, backed by corrections officials, aims to smooth the transition to community life and...

By New York Times – Science
Larry H. Miller COO Frasure Says Dealing With MA Burdens and Higher Acuity Has No ‘Short-Term Fix’
NewsMar 13, 2026

Larry H. Miller COO Frasure Says Dealing With MA Burdens and Higher Acuity Has No ‘Short-Term Fix’

Larry H. Miller Senior Health capped 2025 with the $142 million acquisition of the Kissito Healthcare portfolio, adding six Virginia skilled‑nursing facilities and 532 beds. The integration introduced specialty services such as ventilator, tracheostomy and memory‑care units, expanding the company’s clinical...

By Skilled Nursing News